Yamakoshi Yoshihito, Ohtani Hiroshi, Nagamori Mizuki, Nomura Shinya, Nakagawa Hiroji, Yoshii Mami, Tamura Tatsuro, Toyokawa Takahiro, Tanaka Hiroaki, Muguruma Kazuya, Ohira Masaichi
Dept. of Surgery, Ohno Memorial Hospital.
Gan To Kagaku Ryoho. 2020 Dec;47(13):1933-1935.
A 69-year-old woman, who complained of appetite loss, was diagnosed with Type 3 gastric cancer, and a biopsy resulted in the diagnosis of adenocarcinoma(tub2-por), Group 5. Abdominal computed tomography (CT) revealed bulky metastatic lymph nodes around the stomach and the aorta. The diagnosis was cT4a, cN2, cM1(LYM), cStage ⅣB, and SP therapy(a combination of S-1 and cisplatin) was immediately administered. On the completion of 3 courses of SP therapy, both the primary tumor and lymph nodes markedly decreased in size. Based on this finding, D2 total gastrectomy, No. 16 lymph node dissection, splenectomy, and right adrenal tumor resection were performed. Histopathology showed no residual tumor cells in the stomach or lymph nodes. Postoperatively, she received S-1 therapy, which was discontinued on completion of the first course due to its side effects. She survived for over 7 years postoperatively without receiving chemotherapy and showed no recurrence.
一名69岁女性,因食欲减退就诊,被诊断为3型胃癌,活检诊断为腺癌(tub2-por),第5组。腹部计算机断层扫描(CT)显示胃和主动脉周围有肿大的转移性淋巴结。诊断为cT4a、cN2、cM1(LYM)、c期ⅣB,立即给予SP治疗(S-1和顺铂联合)。完成3个疗程的SP治疗后,原发肿瘤和淋巴结大小均明显减小。基于这一发现,进行了D2全胃切除术、第16组淋巴结清扫术、脾切除术和右肾上腺肿瘤切除术。组织病理学显示胃或淋巴结中无残留肿瘤细胞。术后,她接受了S-1治疗,但由于副作用在第一个疗程结束时停药。她术后存活超过7年,未接受化疗,也未复发。